GRI Bio, Inc.
GRI
$1.60
$0.04412.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -27.85% | 25.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.05% | 56.14% | |||
| Operating Income | 5.05% | -56.14% | |||
| Income Before Tax | 5.06% | 47.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.06% | 47.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.06% | 47.55% | |||
| EBIT | 5.05% | -56.14% | |||
| EBITDA | 5.05% | -56.17% | |||
| EPS Basic | 77.38% | 26.25% | |||
| Normalized Basic EPS | 77.38% | -46.10% | |||
| EPS Diluted | 77.38% | 63.13% | |||
| Normalized Diluted EPS | 77.38% | -46.10% | |||
| Average Basic Shares Outstanding | 319.70% | 7.01% | |||
| Average Diluted Shares Outstanding | 319.70% | 7.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||